The Global Fund should align its catalytic investments with global targets for malaria elimination and eradication
In 2015, the World Health Organization (WHO) reported that among the 106 countries with malaria transmission in 2000, more than half had achieved at least a 75% reduction in new cases. The Global Fund’s investments have been, and continue to be, a key driver of this success. Dedicated funding for malaria has dramatically reduced the malaria burden and sustained these reductions.
Between 29 March and 13 April 2016, the Office of the Inspector General published reports on three investigations – one each in India, Guyana and Bangladesh. The OIG identified non-compliant expenditures ranging from $56,966 for a malaria grant in Guyana to $311,637 for a TB grant in Bangladesh. This article provides a brief summary of the OIG’s findings.
A dispute over clauses in contracts with a sub-recipient in two malaria grants in Cambodia regarding how travel costs should be accounted for was resolved in December 2015, according to Dr. Luciano Tuseo, who heads the World Health Organization’s malaria program in Cambodia. Dr Tuseo is quoted in an article in IRIN News.
As a result of a new tender for insecticide-treated mosquito nets, The Global Fund projects that it will achieve savings of $93 million over the next two years. The Global Fund expects to make $350 million in mosquito net purchases in that time period through its pooled procurement mechanism.
New global fund to fight malaria and other tropical diseases
Global Fund has no immediate plans to promote the inclusion of the new malaria vaccine in the programs it supports
For now, the Global Fund has no plans to promote the inclusion of the new malaria vaccine, “RTS,S”, into the malaria programming it supports. Although the vaccine shows promise, there are concerns about how it can be effectively administered.
The Global Fund that we want: civil society speaks on the need for stronger community-based interventions
More than 120 people gathered on 23-24 June in Bangkok for the Asia-Pacific partnership forum: the second of its kind convened by the Global Fund to solicit voices from civil society and a range of stakeholders to feed into strategy development for the 2017-2021 period.
Kenya will be able to reprogram nearly $30 million within an existing malaria grant to support the scale-up of universal access to vector interventions and treatment. The $30 million consists of $22.5 million in new funding from the allocation Kenya received for malaria under the new funding model, plus about $7 million left over from an earlier malaria grant.
Mozambique, where malaria is nationally endemic and still a major driver of mortality especially among children, is a good example of how collaboration between government, civil society and the private sector can contribute to an effective response to the disease.
Swaziland could become the first country in sub-Saharan Africa to achieve elimination of malaria should it fully and effectively implement its national strategic plan, Aidspan understands from the head of the National Malaria Control Program, Simon Kunene.
In an interview in March, Kunene declared that the country has developed the "most advanced malaria elimination strategy in all of sub-Saharan Africa".